Disclaimer: Orignal content owned by or sourced from third parties. It does not represent the views of 'Nuggets' platform or it's team. AI is used extensively across this platform including for summaries. Accuracy is not guaranteed, there can be mistakes. Any info or content on this platform is not a financial, legal, or investment advice. Do your own research. Refer for complete disclosures:- Terms of Use · Full Disclaimer
"The richer a country gets, the higher percentage of that high per capita income they spend on healthcare." - Aditya Khemka [00:02:25]
"In 1950, US was $2,500 per capita GDP—what India is today. They were spending 28% of their GDP on food, 10% on clothing, and 3% on healthcare... today healthcare is 16% of GDP. We are exactly 75 years behind; the pattern hasn't changed." - Aditya Khemka [00:05:50]
"I want to protect my clients' capital first, grow it later so loss aversion is fairly high... we don't own something that is so frothy in terms of valuations." - Aditya Khemka [00:28:20]
Speakers & Credentials
Aditya Khemka: Fund Manager at InCred Asset Management Company (AMC). He oversees the InCred Healthcare Portfolio (PMS) and the Small & Midcap Strategy. He brings a specialized background in healthcare equity research and portfolio strategy.
PMS AIF WORLD Event Host: Representative framing and introducing key speakers at the PMS AIF WORLD Alpha Summit 2026.
1. Executive Summary
Track Record & Strategy Context: InCred AMC acquired its PMS license in February 2021 and launched its flagship Healthcare Portfolio, which ranked among the top 10 performing PMS strategies out of ~700 in India across CY24 and CY25 [00:00:07].
Macro Thesis: India's current per capita income sits at $2,500 with a 3.3% healthcare expenditure of GDP ($80 per capita per annum), mirroring the exact structural consumption patterns of the US in 1950 [00:01:24].
Consumption Upper Bound: Basic necessities such as food, clothing, and shelter reach a ceiling of physical consumption, whereas healthcare spending expands infinitely into discretionary wellness, longevity, and aesthetics as household wealth grows [00:03:18].
Historical Alpha Generation: Investing in domestic healthcare from 2012 to 2026 delivered a 19.5% CAGR (₹100 growing to ₹1,340) compared to 12.5% CAGR for the BSE 500 (₹100 growing to ₹560), yielding a 7% annual alpha [00:07:32].
Valuation Risk Discipline: In high-growth sub-segments like Contract Development and Manufacturing Organizations (CDMOs), valuation discipline is prioritized by avoiding frothy multiples (60x–100x cash earnings) and allocating to reasonably priced assets (e.g., 12x cash earnings) to enforce capital protection [00:28:07].
2. Chronological Table of Contents
00:00:07 - InCred Healthcare PMS Performance & Top Percentile Track Record
00:01:10 - India’s Per Capita GDP vs. BRICS and Developed World Benchmarks
00:02:14 - The Economic Law of Healthcare Expenditure Expansion
00:02:39 - Glass Ceiling on Physical Goods vs. Unlimited Healthcare Ceiling
00:03:35 - Case Study: South Korea’s $40k Per Capita Economy & Cosmetology
00:04:41 - High-Net-Worth Insurance Case Studies (Ronaldo & Beyoncé)
00:05:22 - Redefining Healthcare: Transitioning from Pharma to Personal Wellness
00:05:50 - Historical Case Study: US Consumption Structural Shift (1950–2010)
00:07:14 - Historical Outperformance: Domestic Healthcare vs. BSE 500 (2012–Present)
00:26:06 - InCred PMS Product Structure & Fund Management Oversight
00:27:02 - Q&A: CDMO Subsector Opportunities, China Biosecure Act, and Molecule Risk
00:28:07 - Valuation Discipline & Loss Aversion in Healthcare Investing
3. Detailed Thematic Summary
Macro Economics of Healthcare & Global Income Comparisons
India currently stands at a total economy size of $4 trillion to $5 trillion across 1.5 billion people, producing a per capita income of approximately $2,500 [00:01:24].
Comparing India’s per capita income ($2,500) to other BRICS nations (Brazil, Russia, China, South Africa at $6,000 to $15,000) and developed markets (Spain to US at $33,000 to $80,000) shows India remains in an early-stage growth phase [00:01:33].
India spends roughly 3.3% of its GDP on healthcare, which translates to an annual spend of $80 per capita [00:02:02].
In contrast, BRICS economies allocate 6% to 10% of their GDP to healthcare, while developed nations allocate 10% to 20% of GDP to the sector [00:02:14].
Economic data highlights a consistent global trend: as per capita income rises, nations allocate a higher percentage of total income to health and wellness [00:02:25].
Consumer Demand Dynamics: Physical Goods Ceiling vs. Wellness
Traditional primary goods—food, clothing, and housing—have absolute physical consumption limits regardless of an individual's financial wealth [00:03:18].
An increase in monthly income from ₹10 lakh to ₹1 crore does not scale basic consumption 10x (e.g., meals consumed remain 3–4 per day, apparel remains capped, and real estate ownership hits practical utility limits) [00:02:44].
Healthcare and personal wellness have no upper spending ceiling, transforming healthcare from basic pharmaceuticals into discretionary self-care, preventative wellness, and aesthetic maintenance [00:03:23].
South Korea’s $40,000 per capita income economy illustrates this trend: 47% of South Korean adults undergo cosmetic surgery procedures [00:03:35].
South Korea has established dedicated cosmetic surgery hubs across three major cities, whereas in India, cosmetic procedures remain restricted to ~0.1% of the population, primarily within niche demographics like Bollywood [00:04:08].
Ultra-high-net-worth individuals demonstrate the uncapped nature of personal body preservation, such as Cristiano Ronaldo insuring his kicking leg for $50 million and Beyoncé insuring her body for $45 million [00:04:41].
Historical US economic data from 1950 shows that when the US was at $2,500 per capita GDP (equivalent to India today), spending was 28% on food, 10% on clothing, and 3% on healthcare [00:05:50].
Between 1950 and 2010, as US per capita GDP rose from $2,500 to $60,000, expenditure shares shifted dramatically: food dropped to 13%, clothing dropped to 3%, while healthcare expanded from 3% to 16% of GDP [00:06:39].
India is following this 75-year structural trajectory, having expanded healthcare spending from 2.5% of GDP in 2012 to 3.5% today [00:06:30].
A ₹100 investment in the broader market (BSE 500) in 2012 grew to ₹560 by 2026 (a 12.5% CAGR) [00:07:32].
Over the same timeframe, a ₹100 investment in domestic healthcare grew to ₹1,340 (a 19.5% CAGR), generating 7% annual alpha and an absolute differential of ₹800 per ₹100 invested [00:07:45].
Portfolio Construction & CDMO Valuation Risk Management
InCred AMC manages three distinct PMS portfolios: Multicap, Small & Midcap, and Healthcare [00:26:32].
While sub-segments like Contract Development and Manufacturing Organizations (CDMO/CRDMO) benefit from global tailwinds like the US China Biosecure Act, execution and clinical trial risks remain high [00:27:16].
Valuations in the CDMO space are bifurcated: market favorites trade between 60x and 100x cash earnings (e.g., Neuland Laboratories, Syngene/Acutas, Laurus Labs), whereas disciplined allocations require lower valuations [00:28:12].
InCred holds positions like Jubilant Pharmova at ~12x cash earnings, protecting client capital against earnings misses that could trigger 20%+ drawdowns in highly valued stocks [00:28:07].
Molecule risk in CDMO portfolios is mitigated by favoring mature entities with diversified product portfolios, ensuring single-molecule failures do not impair overall corporate earnings [00:28:42].
The Reference Vault
4. Data & Figures
Data Point
Value
Context
Timestamp
InCred Healthcare PMS India Ranking
Top 10
Ranking out of ~700 PMS strategies in India across CY24 and CY25
The Satiation Elasticity Framework (Glass Ceiling vs. Infinite Demand): This economic model contrasts goods with finite utility limits (e.g., food, clothing, housing) with goods that have infinite demand potential (e.g., healthcare, longevity, personal wellness) [00:02:39]. Once primary physiological needs are met, additional income does not increase calorie or wardrobe consumption proportionally. Instead, incremental capital flows into life extension, aesthetic optimization, and preventative wellness. In emerging markets like India, this transition shifts healthcare spending from basic disease management to discretionary health enhancement.
The 75-Year Economic Echo Pattern: This framework analyzes consumption patterns in emerging markets by comparing them to historical developed-market datasets [00:05:50]. India’s present economic profile ($2,500 per capita GDP, 25% food spend, 3.5% healthcare spend) aligns with the US economy in 1950. As wealth expands, consumption patterns follow consistent structural trajectories, causing essential goods to shrink as a percentage of GDP while healthcare expands significantly.
Valuation-Gated Loss Aversion in Sector Thematics: This portfolio construction framework addresses high-growth thematic sectors by balancing thematic exposure with strict valuation discipline [00:28:07]. While tailwinds like the US China Biosecure Act drive interest in CDMOs, buying high-multiple assets (60x–100x cash earnings) exposes investors to significant drawdown risk if earnings falter. Allocating to reasonably priced assets (~12x cash earnings) with diversified molecule portfolios helps capture sector growth while preserving capital.
6. Anecdotes
The South Korean Cosmetology Hubs: The speaker references South Korea to illustrate how healthcare spending evolves as per capita income rises [00:03:35]. With a per capita GDP of $40,000, 47% of South Korean adults undergo cosmetic procedures, supported by three dedicated medical cities focused entirely on cosmetic surgery. This contrasts with India's Kota, which focuses on engineering and medical education. The comparison highlights how high-income societies reallocate capital toward aesthetic wellness.
High-Net-Worth Asset Insurance (Ronaldo & Beyoncé): The speaker cites Cristiano Ronaldo insuring his kicking leg for $50 million and Beyoncé insuring her body for $45 million to show how personal wealth changes consumption behavior [00:04:41]. Once material goods are acquired, personal physical preservation becomes a primary focus for capital allocation.
7. References & Recommendations
Companies & Financial Entities
InCred Asset Management Company (AMC): Asset management firm operating PMS and AIF investment strategies in India [00:00:07].
Jubilant Pharmova: Indian CDMO company held in the portfolio at ~12x cash earnings [00:28:07].
Laurus Labs: Indian pharmaceutical and CDMO company referenced for high valuation multiples [00:28:12].
Acutas / Syngene: CDMO entities cited during the Q&A session regarding sector valuations [00:27:41].
Financial Markets & Indexes
BSE 500 Index: Benchmark equity index in India used to measure relative healthcare sector performance from 2012 to 2026 [00:07:32].
Portfolio Management Services (PMS): Specialized investment vehicle in India serving high-net-worth investors across ~700 strategies [00:00:26].
Geopolitical & Regulatory Frameworks
BRICS Economies: Economic grouping (Brazil, Russia, India, China, South Africa) used for per capita income and healthcare spending comparisons [00:01:33].
US China Biosecure Act: Proposed US legislation impacting global supply chains by redirecting CDMO contracts toward non-Chinese suppliers [00:27:24].
Geographic Locations & Cultural References
Kota, Rajasthan: Educational hub in India referenced to contrast academic preparation with South Korea's dedicated aesthetic surgical hubs [00:04:08].
Sep 3, 2026
Blackrock’s Wei Li: Is there an AI bubble? 1 Sept 2026 | Leaders With Joseph Cass | S&P Global Ratings
"When you say bubble it infers that it is bubbly multiple levels, but you look at US tech right now, it's trading at the same multiple as US ex tech. Isn't that crazy?" Wei Li 01:00 http://www.youtube.com/watch?v=JFFmp oTHdM&t=01m00s "It c…